×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| FABINO ENTERPRISES LIMITED | NA | NA | NA | NA | 5.46 | 91.0 |
| Triochem Products Ltd., | NA | NA | NA | NA | 0 | |
| ZENOTECH LABORATORIES LTD. | NA | NA | NA | NA | 340.0 | 81.8 |
| Hemant Surgical Industries Lim | NA | NA | NA | NA | 328 | 41.0 |
| MEDICO REMEDIES LIMITED | 389.1 | 18.18 | 382.51 | 0.22 | 326 | 31.5 |
Zenotech Laboratories Limited, with Security Code 532039, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 7.8 | 10.0 | 8.2 | 10.5 | 10.9 | 8.1 | 9.9 | 8.7 | 10.2 | 11.1 |
| Expenses | 5.2 | 5.9 | 5.6 | 6.0 | 5.7 | 6.3 | 6.5 | 7.4 | 7.4 | 7.6 |
| Operating Profit | 2.6 | 4.0 | 2.7 | 4.5 | 5.3 | 1.8 | 3.4 | 1.4 | 2.9 | 3.5 |
| OPM % | 32.84% | 40.36% | 32.17% | 42.77% | 48.1% | 21.78% | 34.66% | 15.86% | 27.91% | 31.85% |
| Other Income | 1.2 | 1.2 | 1.2 | 1.2 | 0.3 | 1.3 | 0.3 | 2.7 | 2.0 | 1.5 |
| Interest | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Depreciation | 1.8 | 1.8 | 1.8 | 1.8 | 1.7 | 1.7 | 1.7 | 1.7 | 1.8 | 1.7 |
| Profit before tax | 1.9 | 3.5 | 2.1 | 3.9 | 3.8 | 1.4 | 2.0 | 1.0 | 2.5 | 3.3 |
| Tax % | -28.4% | 5.3% | -30.1% | -27.4% | -11.6% | -51.9% | -37% | -42.7% | -45.5% | -59.6% |
| Net Profit | 1.4 | 3.7 | 1.4 | 2.8 | 3.4 | 0.7 | 1.3 | 1.3 | 1.7 | 1.2 |
| EPS in Rs | 0.23 | 0.6 | 0.24 | 0.46 | 0.55 | 0.11 | 0.21 | 0.22 | 0.28 | 0 |
No Consolidated data available.
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 27% |
| 5 Years: | 11% |
| 3 Years: | 6% |
| TTM: | 5% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 1% |
| 3 Years: | -41% |
| TTM: | -45% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 5% |
| 5 Years: | 24% |
| 3 Years: | 5% |
| 1 Year: | 3% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | -20% |
| TTM: | 9% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 29% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 5% |
| 5 Years: | 24% |
| 3 Years: | 5% |
| 1 Year: | 3% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|
| Period | SMA Value | Status |
|---|
| Period | EMA Value | Status |
|---|
| Indicator | Value |
|---|